Cargando…
Diabetes, insulin treatment, and cancer risk: what is the evidence?
Diabetes, in particular type 2, is associated with an increased incidence of cancer. Although the mortality attributable to cancer in type 2 diabetes is overshadowed by that due to cardiovascular disease, emerging data from epidemiologic studies suggest that insulin therapy may confer added risk for...
Autores principales: | Azar, Madona, Lyons, Timothy J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948398/ https://www.ncbi.nlm.nih.gov/pubmed/20948845 http://dx.doi.org/10.3410/M2-4 |
Ejemplares similares
-
Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
por: Cleland, S. J., et al.
Publicado: (2013) -
Type 2 Diabetes Mellitus, Oral Diabetic Medications, Insulin Therapy, and Overall Breast Cancer Risk
por: Ahmadieh, Hala, et al.
Publicado: (2013) -
Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?
por: Otto-Buczkowska, Ewa, et al.
Publicado: (2017) -
Link between insulin resistance and hypertension: What is the evidence from evolutionary biology?
por: Zhou, Ming-Sheng, et al.
Publicado: (2014) -
Serum Carotenoids and Fat-Soluble Vitamins in Women With Type 1 Diabetes and Preeclampsia: A longitudinal study
por: Azar, Madona, et al.
Publicado: (2011)